Loading...
BVMFPNVL3
Market cap211mUSD
Dec 23, Last price  
8.78BRL
1D
-0.79%
1Q
-11.85%
Jan 2017
-60.63%
Name

Dimed SA Distribuidora de Medicamentos

Chart & Performance

D1W1MN
BVMF:PNVL3 chart
P/E
14.12
P/S
0.29
EPS
0.62
Div Yield, %
2.19%
Shrs. gr., 5y
1.86%
Rev. gr., 5y
12.90%
Revenues
4.46b
+11.79%
733,526,000832,805,000933,239,0001,074,630,0001,190,659,0001,345,632,0001,524,000,0003,480,840,0001,887,076,0001,986,026,0004,257,464,0002,258,246,0002,432,246,0002,724,680,0002,819,110,0003,225,408,0003,990,475,0004,461,017,000
Net income
93m
+7.60%
14,402,00014,173,0009,689,00029,697,00030,773,00037,422,00047,105,00056,145,00049,359,00045,268,00053,059,00059,798,00074,982,00076,755,00056,151,00079,426,00086,345,00092,905,000
CFO
297m
+44.36%
10,209,00039,609,0008,081,00050,593,00019,237,00062,298,00022,902,00071,447,000101,603,00040,885,000109,880,000128,796,000130,983,000131,859,000205,480,000296,621,000
Dividend
Oct 03, 20240.090381 BRL/sh
Earnings
Mar 12, 2025

Profile

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal care and beauty products, cosmetics, and dermocosmetics in Brazil. It operates in Retail and Wholesale segments. The company offers products through distribution centers in the states of Rio Grande do Sul, Paraná, and Espírito Santo. It operates 517 stores in Rio Grande do Sul, Santa Catarina, Paraná, and São Paulo. The company was formerly known as Panvel S.A. Drogarias e Farmacias and changed its name to Dimed S.A. Distribuidora de Medicamentos in April 2000. The company is headquartered in Eldorado do Sul, Brazil.
URL
https://www.panvel.com/
IPO date
Oct 29, 1992
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,461,017
11.79%
3,990,475
23.72%
3,225,408
14.41%
Cost of revenue
4,343,972
2,968,078
2,416,473
Unusual Expense (Income)
NOPBT
117,045
1,022,397
808,935
NOPBT Margin
2.62%
25.62%
25.08%
Operating Taxes
(1,321)
(7,915)
3,813
Tax Rate
0.47%
NOPAT
118,366
1,030,312
805,122
Net income
92,905
7.60%
86,345
8.71%
79,426
41.45%
Dividends
(28,721)
(24,752)
(20,442)
Dividend yield
1.44%
1.64%
1.02%
Proceeds from repurchase of equity
1,360
(160)
(19,723)
BB yield
-0.07%
0.01%
0.99%
Debt
Debt current
266,896
270,488
189,137
Long-term debt
1,395,943
1,237,768
1,058,899
Deferred revenue
(1,167)
(8,944)
Other long-term liabilities
13,851
15,678
18,101
Net debt
1,414,056
1,482,537
1,193,596
Cash flow
Cash from operating activities
296,621
205,480
131,859
CAPEX
(114,419)
(181,637)
(135,580)
Cash from investing activities
(196,558)
(131,085)
14,905
Cash from financing activities
(97,825)
(103,115)
(222,436)
FCF
243,267
806,005
628,303
Balance
Cash
245,389
157,355
209,651
Long term investments
3,394
(131,636)
(155,211)
Excess cash
25,732
Stockholders' equity
1,201,998
1,137,530
1,079,604
Invested Capital
2,184,222
1,963,630
1,715,478
ROIC
5.71%
56.01%
47.89%
ROCE
5.30%
52.04%
46.91%
EV
Common stock shares outstanding
149,717
149,145
149,910
Price
13.36
31.76%
10.14
-23.87%
13.32
-38.90%
Market cap
2,000,220
32.26%
1,512,330
-24.26%
1,996,799
-39.55%
EV
3,414,276
2,994,867
3,190,395
EBITDA
317,199
1,206,965
966,709
EV/EBITDA
10.76
2.48
3.30
Interest
102,573
70,025
37,124
Interest/NOPBT
87.64%
6.85%
4.59%